The combined signatures of G protein-coupled receptor family and immune landscape provide a prognostic and therapeutic biomarker in endometrial carcinoma.
J Cancer Res Clin Oncol
; 149(16): 14701-14719, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-37584707
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Endometrial Neoplasms
/
Carcinoma, Endometrioid
Type of study:
Prognostic_studies
Limits:
Female
/
Humans
Language:
En
Journal:
J Cancer Res Clin Oncol
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: